Recent Finacing
Recent Raise
Navrogen is a preclinical biotechnology company discovering tumor-produced Humoral Immuno-Oncology factors via proprietary screening, engineering and diagnostic assays, and developing HIO-targeted therapeutics including an anti-mesothelin ADC and NK activators.
